Market revenue in 2023 | USD 62.2 million |
Market revenue in 2030 | USD 112.7 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Research & Manufacturing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Research & Manufacturing |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Roche Holding AG, Qiagen NV, Becton Dickinson & Co, Siemens Healthineers AG ADR, Thermo Fisher Scientific Inc, Hologic Inc, Koninklijke Philips NV, Illumina Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood cancer diagnostics market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 68.65% in 2023. Horizon Databook has segmented the Argentina blood cancer diagnostics market based on hospitals, outpatient facilities, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of secondary blood cancers, often associated with treatments for other types of cancers or underlying health conditions, is on the rise in Argentina. Secondary blood cancers include conditions such as therapy-related myeloid neoplasms and post-transplant lymphoproliferative disorders.
Healthcare providers are integrating advanced diagnostic modalities to detect and manage secondary blood cancers promptly, contributing to the growth of the blood cancer diagnostics market in the country.
Rising preference among patients and healthcare providers in Argentina for minimally invasive diagnostic techniques for blood cancers is driving the market growth. Procedures such as bone marrow biopsy, fine-needle aspiration, & peripheral blood smear analysis are less invasive and offer quicker recovery times compared to traditional diagnostic methods.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina blood cancer diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Argentina blood cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account